Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05991882 · ClinicalTrials.gov registry record · NA

Mobile Intervention for Simultaneous Alcohol and Marijuana Use in Young Adults

A NA study of Alcohol Drinking and Cannabis Use, sponsored by Kaiser Permanente.

Recruiting
Registry status
NA
Development phase
136
Enrollment target
1
Study location

NCT05991882: Recruiting NA study of Alcohol Drinking and Cannabis Use, sponsored by Kaiser Permanente.

NCT05991882 is a NA study of Alcohol Drinking and Cannabis Use that is actively recruiting participants, run by Kaiser Permanente. The registered enrollment target is 136 participants, below the 629-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05991882, a NA study of Alcohol Drinking and Cannabis Use, is actively recruiting participants, sponsored by Kaiser Permanente.

RECRUITING
Registry status
NA
Development phase
136 participants
Enrollment target
1
Study location

Study Summary

The goal of this treatment development project is to develop an adaptive ecological momentary intervention (a-EMI) for young adults using marijuana and alcohol that is grounded in self-regulation and social cognitive theories. To determine the most efficacious intervention strategies, the investigators will test variations of intervention components to identify the best combination. The study will take place at the Center for Integrated Health Care Research at Kaiser Permanente Hawaii (KPHI), located in Honolulu (island of Oahu). Following pilot testing with 6 participants, the study team will assess the feasibility and efficacy of intervention components on two primary outcomes (negative consequences and protective behavioral strategies \[PBS\]) using a fractional factorial experimental design, with post-intervention assessment and one- and three-month follow-ups. 136 diverse young adults recruited from KPHI who report current simultaneous alcohol and marijuana (SAM) use will be randomly assigned to one of eight groups, representing experimental conditions that include or do not include intervention strategies focused on craving reduction and PBS. As a result of this process, individual and/or combined components that lead to improved outcomes will be retained in a subsequent randomized controlled trial, while ineffective components will be eliminated.

Primary Outcome

Changes in negative consequences will be assessed using a measure that assesses alcohol, marijuana, and SAM use negative consequences. Items are rated dichotomously (yes/no).

Interventions

  • BEHAVIORAL Condition 1: Craving daily+PBS daily
  • BEHAVIORAL Condition 2: Craving daily+PBS trigger
  • BEHAVIORAL Condition 3: Craving trigger+PBS daily
  • BEHAVIORAL Condition 4: Craving trigger+PBS trigger
  • BEHAVIORAL Condition 5: PBS daily+ PBS trigger

Study Locations (1)

Hawaii

  • Kaiser Permanente Hawaii, Center for Integrated Health Care Research - Honolulu

Trial Details

FieldValue
Enrollment Target 136 participants
Start Date 2024-04-01
Est. Completion 2026-05-01
Phase NA
Kaiser Permanente

294 total trials

What NCT05991882 shows while recruiting

NCT05991882 is an interventional study that assigns participants to a tested intervention. The registered 136 participants enrollment target is mid-sized for trials with a published cap, below the 629-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (78% lower).

The record links to 2 conditions, with Alcohol Drinking appearing as the primary indexed condition, and to 5 interventions - of which Condition 1: Craving daily+PBS daily is the first listed.

NCT05991882 reports a single indexed study location in Hawaii.

Frequently Asked Questions

What is clinical trial NCT05991882 about?

NCT05991882 is a clinical study titled "Mobile Intervention for Simultaneous Alcohol and Marijuana Use in Young Adults". The goal of this treatment development project is to develop an adaptive ecological momentary intervention (a-EMI) for young adults using marijuana and alcohol that is grounded in self-regulation and social cognitive theories. To determine the most efficacious intervention strategies, the investigat...

What is the current status of trial NCT05991882?

This trial is currently recruiting. It is a NA study. The enrollment target is 136 participants. The study started on 2024-04-01. Estimated completion is 2026-05-01.

What conditions does trial NCT05991882 study?

This clinical trial studies the following conditions: Alcohol Drinking, Cannabis Use.

What interventions are being tested in trial NCT05991882?

The interventions under investigation include: Condition 1: Craving daily+PBS daily (BEHAVIORAL), Condition 2: Craving daily+PBS trigger (BEHAVIORAL), Condition 3: Craving trigger+PBS daily (BEHAVIORAL), Condition 4: Craving trigger+PBS trigger (BEHAVIORAL), Condition 5: PBS daily+ PBS trigger (BEHAVIORAL).

Who is sponsoring clinical trial NCT05991882?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05991882 being conducted?

This trial has 1 study location across Hawaii. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alcohol Drinking

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05991882's enrollment target sits among peer trials

136 50th of 85 higher than 36 of 85 other Alcohol Drinking trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Alcohol Drinking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01555892 · 136 participants · Phase 1

    Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE

  • NCT03216525 · 136 participants · Phase 3

    Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol

  • NCT04476901 · 136 participants · Phase 2

    Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy

  • NCT04603898 · 136 participants · NA

    Oxalate Formation From Ascorbic Acid

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05991882, the US trial registry maintained by the National Library of Medicine. NCT05991882 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.